Cannabis Report
High Times
Home > Boards > US OTC > Medical - Drugs >

Biostar Pharmaceuticals, Inc. (BSPM)

BSPM RSS Feed
Add BSPM Price Alert      Hide Sticky   Hide Intro
Moderator: finesand
Search This Board: 
Last Post: 8/8/2018 11:29:58 PM - Followers: 84 - Board type: Free - Posts Today: 0

http://www.biostarpharmaceuticals.com/

http://finance.yahoo.com/q/ks?s=BSPM+Key+Statistics 

Biostar Pharmaceuticals, Inc., through its subsidiary, Shaanxi Biostar Biotech, Ltd., discovers, develops, manufactures, and markets over-the-counter and prescription pharmaceutical products, and nutrient products for various diseases and conditions in the People's Republic of China. Its primary product is Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B. The company's products also include Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products comprise Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. In addition, the company holds licenses to produce and sell 13 nutrient products. Biostar Pharmaceuticals sells its products to pharmacies directly, as well as through a network of 20 distributors. It has research and development agreements with Fourth Military Medical University Xijing Hospital State Drug Clinical Research Center to conduct clinical trial for new drugs. The company was founded in 1995 and is headquartered in Xianyang City, the People's Republic of China. 

Recent Timeline

- 2011-10-11 $17.43 Acquisition of Shaanxi Weinan Huaren Pharmaceuticals
- 2012-04-04 RS 1:3
- 2013-04-xx $4.34 New All Time Low
- 2015-08-xx $4.34 Going Lower
- 2015-09-30 $4.55 3Q2015 where Aoxin GMP Certification Issues Started, No Production
- 2015-11-23 $4.20 3Q2015 PR and SP sliding further
- 2016-05-02 RS 1:7, $1.08 New All Time Low in May 2016
- 2016-10-11 Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis ($7.5M revs within 2 years starting in 2017?)
- 2016-10-18 Completes Previously Announced Registered Direct Financing - 425k shares @ $4.55/sh & 212.5k Warrants @ $5.55/sh
- 2016-12-01 Shaanxi Weinan Operations temporarily suspended since December 2016 (see 10-Q of 3Q17 page F-6)
- 2017-08-28 Receipt of Nasdaq Continued Listing Deficiency Notice – Late 2Q17 10-Q, 60 days deadline until 2017-10-21 for compliance plan
- 2017-10-13 Company replied to a SEC request: Assets protecting loans and deposits
- 2017-10-23 Company submitted the compliance plan after 62 days (3Q17 p3)
- 2017-11-10 NASDAQ approved plan and extended grace period until 2017-11-30, 80 days after notice, 20 days after deadline and 18 days after plan submission
- 2017-11-10 Received GMP Certification and Company License Renewal already
- 2017-11-15 Company filed its 2Q17 10-Q
- 2017-11-20 Company filed its 3Q17 10-Q
- 2017-12-04 Regains Compliance with NASDAQ Continued Listing Requirement – 2Q17 & 3Q17 10-Q filed
- 2018-01-21 Week O $2.15 H $5.97 L $2.02 C $3.32
- 2018-01-29 Liao Huiping promoted to BOD, General Manager Shaanxi Weinan
- 2018-01-31 New Auditor Centurion ZD CPA Limited, replacing resigning Mazars CPA due to withdrawing from auditing public companies in the U.S.
- 2018-01-31 PR'ed: Shaanxi Aoxing Pharmaceutical Renewed its GMP Certification - Resume production in coming months, preparations ongoing (PR'ed 2018-02-07)
- 2018-02-11 Week O $5.00 H $5.02 L $3.76 C $3.86
- 2018-02-21 Plans to Launch a New eCommerce Sales Platform completed by the end of March 2018 & launch during 2Q18 with production
- 2018-04-23 Receipt of Nasdaq Continued Listing Deficiency Notice due to being a late 10-K filer (again)
- 2018-04-23 Week O $2.83 H $2.94 L $2.02 C $2.15
- 2018-04-27 Newly produced Drugs are avail for sale in Shaanxi Province already
- 2018-06-04 BOD Liao Huiping takes over CEO Wang’s Ownership, Company’s assets freed beforehand!

Share Structure, Ownership

OS is 2.6372M common shares (10-Q) as of 2017-11-20
BOD Liao Huiping owns 0.4270M as of SC 13D 2017-06-04
CEO Wang owns 0.0095M as of SC 13D 2017-06-04
Institutions own 0.1059M, increased by 248% last period of 2018-03-31
Total of 0.5424M shares or 20.55% of OS
Free float is 2.0976M or 79.45% of OS
Short Interest is just at 0.1624M or 7.74% of float on 2018-06-15
 

NAV (Equity) Value

- $36.88M or $13.69/sh equity, including
- $26.58M or $10.07/sh deposit value, having $16.03M or $6.07/sh refundable

Historical Evaluation on using 12month MA and 10-K data + Projections + Deposit Details

(Using 12 month MA for stock price and hence MCAP)

Historical and Future Evaluation

Annual YoY Fundamentals using 12 month MA for lower stock price

Fundamentals

 


 

Cannabis Report
High Times
BSPM
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BSPM News: Current Report Filing (8-k) 08/24/2018 09:05:36 AM
BSPM News: Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq 08/23/2018 08:51:45 AM
BSPM News: Current Report Filing (8-k) 07/25/2018 04:34:08 PM
BSPM News: Current Report Filing (8-k) 07/06/2018 04:32:18 PM
BSPM News: Statement of Beneficial Ownership (sc 13d) 07/02/2018 05:26:03 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1627  Sticky Note Pivot Value Play - Compilation (update) finesand 07/18/18 07:45:21 PM
#1634   Potential Suspension on Friday if Nasdaq doesn't give finesand 08/08/18 11:29:58 PM
#1633   smart- it is a long & complicated story finesand 07/28/18 09:03:23 AM
#1632   * * $BSPM Video Chart 07-27-18 * * ClayTrader 07/27/18 05:00:54 PM
#1631   manipulated GAP & TRAP [SMART MONEY] 07/27/18 02:01:29 PM
#1630   * * $BSPM Video Chart 07-26-18 * * ClayTrader 07/26/18 04:44:31 PM
#1629   Delisting Determination finesand 07/26/18 05:59:00 AM
#1628   Delisting. Back under a buck. willlbone 07/25/18 03:49:51 PM
#1627   Pivot Value Play - Compilation (update) finesand 07/18/18 07:45:21 PM
#1626   Look at Yue Kai Peng Group here, the finesand 07/05/18 07:10:58 AM
#1625   Re: Ownership Reorg – A Clean Restart finesand 07/04/18 08:29:13 PM
#1624   Ownership Reorg – A Clean Restart finesand 07/03/18 09:15:51 AM
#1623   two blogs were added, detailing the base article finesand 07/02/18 03:22:01 PM
#1622   Biostar Pharmaceuticals (BSPM) Pivot Value Play (update) finesand 06/29/18 02:49:16 PM
#1621   BSPM’s Delinquency Status finesand 06/28/18 02:04:21 PM
#1620   Biostar Pharmaceuticals (BSPM) Pivot Value Play finesand 06/27/18 05:51:11 AM
#1619   Interesting Findings re Shanxi Weinan Huaren Pharmaceuticals finesand 06/26/18 03:57:16 PM
#1618   Updated spreadsheet in Intro, etc finesand 06/19/18 06:23:33 PM
#1617   seriously, we believe they just file late as finesand 06/19/18 03:34:34 PM
#1616   Over 6/18 financial filing + listing deadline again finesand 06/19/18 01:35:52 PM
#1615   tick tock: 6/18 + 15 days? finesand 06/10/18 05:30:18 PM
#1614   Status update? finesand 05/16/18 11:26:57 PM
#1613   Where is everyone??? Dream_Weaving 05/15/18 10:00:05 AM
#1612   oh, this truly has the potential finesand 05/05/18 06:51:15 PM
#1611   I agree that this is coming back to KlingKong 05/05/18 02:06:12 PM
#1610   Nice Pre-Official Reaction Today finesand 05/04/18 06:17:03 PM
#1609   * * $BSPM Video Chart 05-04-18 * * ClayTrader 05/04/18 05:01:01 PM
#1608   And more just below europtiger 05/04/18 11:32:37 AM
#1607   Got me 3,20‘s europtiger 05/04/18 11:31:38 AM
#1606   same site's shop finder shows not only one finesand 04/30/18 07:33:07 PM
#1605   valid for 24 month finesand 04/30/18 07:21:44 PM
#1604   New Product on Sale in Shaanxi Province finesand 04/27/18 04:20:51 PM
#1603   Expiration date end of 2019 with a 24 finesand 04/27/18 01:24:20 PM
#1602   Research Result of Last Days finesand 04/27/18 11:00:36 AM
#1601   We started buying slowly again, neatly below 200dma finesand 04/26/18 04:16:59 PM
#1600   Sideline until 10-K + financials shown finesand 04/19/18 10:33:34 AM
#1599   Bought Shares At 4.O4 zino 03/19/18 10:42:21 AM
#1598   O/S Just 2,637,OOO zino 03/19/18 10:40:54 AM
#1597   NAV (Equity) Value is finesand 03/02/18 12:41:06 PM
#1596   NAV (Equity) Value is finesand 03/02/18 12:21:11 PM
#1595   a little bit more color on the deposits finesand 03/01/18 08:53:59 PM
#1594   Updated Historical Revenue Evaluation finesand 02/28/18 09:24:50 PM
#1593   Relevant for 4Q17 and 2018 Revenue? finesand 02/28/18 12:24:21 PM
#1592   Good info. Thanks QuidRunner 02/28/18 05:46:57 AM
#1591   BSPM Revenue Evaluation, Past & Future finesand 02/27/18 11:33:26 PM
#1590   Consolidation, Low Volume Slide -> Rise finesand 02/27/18 07:07:36 PM
#1589   Financials For Production Relaunch / Sales Platform finesand 02/21/18 10:47:09 PM
#1588   3.42 x 100 3.55 x 12220 pietro13 02/21/18 03:52:33 PM
#1587   Shaanxi Aoxing Pharmaceutical Impact finesand 02/21/18 12:52:25 AM
#1586   Nice day today. QuidRunner 02/08/18 07:33:30 PM
#1585   Oh yeah we going up tomorrow ladies and gents!!!! winna 02/07/18 07:39:45 PM
PostSubject